Form 8-K - Current report:
SEC Accession No. 0001213900-24-060165
Filing Date
2024-07-09
Accepted
2024-07-09 17:09:54
Documents
17
Period of Report
2024-07-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209174-8k_aditxtinc.htm   iXBRL 8-K 47966
2 FORM OF WARRANT (JULY 2024) ea020917401ex4-1_aditxtinc.htm EX-4.1 174044
3 FORM OF SECURITIES PURCHASE AGREEMENT (JULY 2024) ea020917401ex10-1_aditxtinc.htm EX-10.1 258756
4 FORM OF SENIOR NOTE (JULY 2024) ea020917401ex10-2_aditxtinc.htm EX-10.2 114148
5 FORM OF AMENDMENT TO COMMON STOCK PURCHASE WARRANTS (JULY 2024) ea020917401ex10-3_aditxtinc.htm EX-10.3 10961
  Complete submission text file 0001213900-24-060165.txt   921549

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adtx-20240709.xsd EX-101.SCH 3009
7 XBRL LABEL FILE adtx-20240709_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE adtx-20240709_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0209174-8k_aditxtinc_htm.xml XML 3784
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241108070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)